Real-world effectiveness, safety, and health-related quality of life in people living with HIV receiving bictegravir/emtricitabine/tenofovir alafenamide—12-month results of the BICSTaR French cohort
These French real-world data confirm the effectiveness, safety, and tolerability of B/F/TAF in TN and TE participants with a high prevalence of comorbidities.
Authors
- Pascale Leclercq (ORCID: https://orcid.org/0000-0002-3113-5261)
- Claudine Duvivier (ORCID: https://orcid.org/0000-0001-5696-4173)
- François Durand (ORCID: https://orcid.org/0000-0002-0357-1090)
- Hugues Cordel
- Frank Tollinchi
- Sabrinel Sahali
- Alicia Castro Gordon
- Tali Cassidy (ORCID: https://orcid.org/0000-0003-1268-3331)
- Marina Karmochkine
- Fabrice Bonnet (ORCID: https://orcid.org/0000-0001-5927-4178)
- Laurent Hocqueloux (ORCID: https://orcid.org/0000-0002-2264-4822)
- David Thorpe (ORCID: https://orcid.org/0000-0002-3649-1724)
- Olivier Robineau (ORCID: https://orcid.org/0000-0001-8196-5442)
- Matteo Vassallo (ORCID: https://orcid.org/0000-0002-3605-3871)
- Colin Deschanvres
Institutions
- Centre National de la Recherche Scientifique (FR)
- Université de Bordeaux (FR)
- Inserm (FR)
- Institut Pasteur (FR)
- Université Paris Cité (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Bordeaux Population Health (FR)
- Gilead Sciences (United Kingdom) (GB)
- Centre Hospitalier de Tourcoing (FR)
- Hôpital Saint Joseph (FR)
- Hôpital Avicenne (FR)
- Hôtel-Dieu de Paris (FR)
- Centre hospitalier universitaire d'Orléans (FR)
- Centre Hospitalier de Cannes (FR)
- Bicêtre Hospital (FR)
- Gilead Sciences (France) (FR)
Publication Details
- Journal
- IJID Regions
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1016/j.ijregi.2025.100685
- Citations
- 1
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.25
Funders
- Gilead Sciences